Evidence map›Paper›PMID 31589660›Full record

ArticlePLoS pathogens2019

Phage resistance at the cost of virulence: Listeria monocytogenes serovar 4b requires galactosylated teichoic acids for InlB-mediated invasion.

Eric T Sumrall, Yang Shen, Anja P Keller, Jeanine Rismondo, Maria Pavlou, Marcel R Eugster, Samy Boulos, Olivier Disson, Pierre Thouvenot, Samuel Kilcher and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 112 citations in OpenAlex.

  1. Engineering the probioticSynthetic and systems biotechnology · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Phage P100 resistance in clinical and foodborneCurrent research in microbial sciences · 2026
    Article
  10. NovelInternational journal of molecular sciences · 2025
    Article
  11. Article
  12. Journal of bacteriology · 2025
    Article
  13. Article
  14. The Virulence Factor LLO ofFoods (Basel, Switzerland) · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Eric T SumrallInstitute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.
Yang ShenInstitute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.ORCID 0000-0003-4278-1477
Anja P KellerInstitute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.ORCID 0000-0001-5126-2578
Jeanine RismondoSection of Microbiology and MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
Maria PavlouInstitute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
Marcel R EugsterInstitute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.
Samy BoulosInstitute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-0442-2505
Olivier DissonBiology of Infection Unit, Institut Pasteur, Paris, France.
Pierre ThouvenotBiology of Infection Unit, Institut Pasteur, Paris, France.
Samuel KilcherInstitute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.
Bernd WollscheidInstitute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-3923-1610
Didier Cabanesi3S - Instituto de Investigação e Inovação em Saúde; Institute for Molecular and Cell Biology, University of Porto, Porto, Portugal.ORCID 0000-0002-4001-1332
Marc LecuitBiology of Infection Unit, Institut Pasteur, Paris, France.ORCID 0000-0002-4491-1063
Angelika GründlingSection of Microbiology and MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.ORCID 0000-0002-6235-8687
Martin J LoessnerInstitute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-8162-2631
ETH Zurich · CHImperial College London · GBInserm · FRDélégation Paris 5 · FRUniversidade do Porto · PT

Funding

Medical Research Council MR/P011071/1Medical Research Council MR/P028225/1Wellcome TrustWellcome Trust 100289
6 · The paper itself

Abstract

The intracellular pathogen Listeria monocytogenes is distinguished by its ability to invade and replicate within mammalian cells. Remarkably, of the 15 serovars within the genus, strains belonging to serovar 4b cause the majority of listeriosis clinical cases and outbreaks. The Listeria O-antigens are defined by subtle structural differences amongst the peptidoglycan-associated wall-teichoic acids (WTAs), and their specific glycosylation patterns. Here, we outline the genetic determinants required for WTA decoration in serovar 4b L. monocytogenes, and demonstrate the exact nature of the 4b-specific antigen. We show that challenge by bacteriophages selects for surviving clones that feature mutations in genes involved in teichoic acid glycosylation, leading to a loss of galactose from both wall teichoic acid and lipoteichoic acid molecules, and a switch from serovar 4b to 4d. Surprisingly, loss of this galactose decoration not only prevents phage adsorption, but leads to a complete loss of surface-associated Internalin B (InlB),the inability to form actin tails, and a virulence attenuation in vivo. We show that InlB specifically recognizes and attaches to galactosylated teichoic acid polymers, and is secreted upon loss of this modification, leading to a drastically reduced cellular invasiveness. Consequently, these phage-insensitive bacteria are unable to interact with cMet and gC1q-R host cell receptors, which normally trigger cellular uptake upon interaction with InlB. Collectively, we provide detailed mechanistic insight into the dual role of a surface antigen crucial for both phage adsorption and cellular invasiveness, demonstrating a trade-off between phage resistance and virulence in this opportunistic pathogen.

Indexed as

VirulenceBacterial ProteinsBacteriophagesCaco-2 CellsCell WallGalactoseHep G2 CellsHumansListeria monocytogenesMembrane ProteinsMutationSerogroupTeichoic AcidsBacterial ProteinsGalactoseinlB protein, Listeria monocytogenesMembrane ProteinsTeichoic Acids

Identifiers

PMID31589660
PMCPMC6779246
OpenAlexW2977257606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.